Relpax: profile and news

Industry Watch: Pharma Marketers Up the Dosage  16 May 2006
For example, a search for the phrase "migraine treatment" yields Pfizer's Relpax and Johnson & Johnson/Ortho-McNeil's Topamax Web sites as the No. 1 and No. ... - MediPost Publications,

Full Story of Relpax Patent Protection Not Told by Orange Book  May 1, 2006
Pfizer’s oral anti-migraine medicine Relpax, (Eletriptan hydrobromide) appears to have more patent protection than meets the eye. ... - PR Web (press release),

Full Story of Relpax Patent Protection Not Told by Orange Book?  May 1, 2006
...(PRLEAP.COM) SYDNEY, NSW, May 01, 2006 – Pfizer’s oral anti-migraine medicine Relpax, (Eletriptan hydrobromide) appears to have more patent protection than ... - PR Leap (press release),

Pfizer First-Quarter 2006 Financial Results Reflect Operating and ...  Apr 19, 2006
...therapeutic areas, including cardiovascular/metabolic diseases (Caduet up 147 percent); central- nervous-system disorders (Geodon up 32 percent, Relpax up 24 ... - International News Service,

Ask the Clinician: Answers to Readers' Questions  Apr 24, 2006
...days She has been on Elavil, Topamax, and currently Inderal So far none of the abortive medications have helped (Zomig, Midrin, Frova, Relpax, Imitrex pill & ... - About - News & Issues,

Health Products Research Reports Key Findings on Pharmaceutical ...  Apr 24, 2006
In the Anti-Migraine category, Imitrex® (GSK), Relpax® (Pfizer) and Axert® (Ortho-McNeil) were the most actively promoted medications. ... - Yahoo! News (press release)

Health Products Research Reports Key Findings on Pharmaceutical ...  Apr 24, 2006
In the Anti-Migraine category, Imitrex(R) (GSK), Relpax(R) (Pfizer) and Axert(R) (Ortho-McNeil) were the most actively promoted medications. ... - PR Newswire (press release),